本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

20.52
-1.1100-5.13%
成交量:105.32萬
成交額:2,226.97萬
市值:24.60億
市盈率:-27.63
高:21.84
開:21.75
低:20.48
收:21.63
52周最高:21.84
52周最低:8.03
股本:1.20億
流通股本:8,558.07萬
量比:0.68
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-0.7427
每股收益(LYR):-1.1578
淨資產收益率:-57.33%
總資產收益率:-13.46%
市淨率:17.70
市盈率(LYR):-17.72

資料載入中...

2025/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities